Eiko Lifescience

34
Sell
  • Market Cap: Micro Cap
  • Industry: Specialty Chemicals
  • ISIN: INE666Q01016
  • NSEID:
  • BSEID: 540204
INR
51.50
0.39 (0.76%)
BSENSE

Dec 19

BSE+NSE Vol: 4.7 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Eiko Lifescience Cash flow Statement
Figures in Cr
Consolidated Cash Flow Results
Mar'25
Mar'20
Mar'19
Mar'18
No of Months
12
12
12
12
Profit Before Tax
3.00
-4.00
-1.00
0.00
Adjustment
0.00
0.00
0.00
0.00
Changes In working Capital
0.00
4.00
0.00
0.00
Cash Flow after changes in Working Capital
3.00
0.00
0.00
0.00
Cash Flow from Operating Activities
2.00
0.00
0.00
0.00
Cash Flow from Investing Activities
-11.00
0.00
0.00
0.00
Cash Flow from Financing Activities
6.00
0.00
0.00
0.00
Net Cash Inflow / Outflow
-1.00
0.00
0.00
0.00
Opening Cash & Cash Equivalents
13.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
11.00
0.00
0.00
0.00
Figures in INR Cr
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Eiko Lifescience
Markets Mojo
Figures in Cr
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Profit Before Tax
3.06
-0.06
3.00
5200.00%
Adjustment
-0.15
9.63
-9.00
-101.56%
Changes In working Capital
0.32
1.48
-1.00
-78.38%
Cash Flow after changes in Working Capital
3.23
11.05
-8.00
-70.77%
Cash Flow from Operating Activities
2.92
10.82
-8.00
-73.01%
Cash Flow from Investing Activities
-11.44
1.53
-12.00
-847.71%
Cash Flow from Financing Activities
6.96
-2.51
8.00
377.29%
Net Cash Inflow / Outflow
-1.57
9.84
-10.00
-115.96%
Opening Cash & Cash Equivalents
13.35
6.38
7.00
109.25%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
11.78
16.22
-5.00
-27.37%
Cash Flow - Snapshot (Consolidated) - Mar'25
stock-summary

Not Applicable: The company has declared_date for only one period

Mar'25
Change(%)
Cash Flow from Operating Activities
2.92
NA
NA